Trial Profile
Clinical outcome of maraviroc-containing therapy in heavily pre-treated HIV-1-infected patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Nov 2016
Price :
$35
*
At a glance
- Drugs Maraviroc (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics